On the public citation graph
The impact of opioid substitution therapy on mortality post‐release from prison: retrospective data linkage study
0 signed · 261 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/14651858.cd004145.pub4openalex-snapshot
Oral substitution treatment of injecting opioid users for prevention of HIV infection
inferredcites →https://doi.org/10.1007/978-1-4757-3294-8openalex-snapshot
Modeling Survival Data: Extending the Cox Model
inferredcites →https://doi.org/10.1016/j.drugalcdep.2007.05.022openalex-snapshot
A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release
inferredcites →https://doi.org/10.1016/j.drugalcdep.2009.05.021openalex-snapshot
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved
inferredcites →https://doi.org/10.1016/j.drugalcdep.2009.06.015openalex-snapshot
Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide Survey
inferredcites →https://doi.org/10.1016/j.drugalcdep.2010.07.002openalex-snapshot
Corrigendum to “Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey” [Drug Alcohol Depend., 105(1–2) 2009 83–88]
inferredcites →https://doi.org/10.1016/j.drugpo.2006.11.015openalex-snapshot
The impact of substitution treatment in prisons—A literature review
inferredcites →https://doi.org/10.1016/s0140-6736(13)61530-5openalex-snapshot
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010
inferredcites →https://doi.org/10.1016/s1473-3099(08)70305-0openalex-snapshot
Interventions to reduce HIV transmission related to injecting drug use in prison
inferredcites →https://doi.org/10.1017/cbo9780511543692openalex-snapshot
Mortality amongst Illicit Drug Users
inferredcites →https://doi.org/10.1017/cbo9780511543692.003openalex-snapshot
Mortality amongst illicit drug users
inferredcites →https://doi.org/10.1046/j.1360-0443.2003.00264.xopenalex-snapshot
Male drugs‐related deaths in the fortnight after release from prison: Scotland, 1996–99
inferredcites →https://doi.org/10.1056/nejmsa064115openalex-snapshot
Release from Prison — A High Risk of Death for Former Inmates
inferredcites →https://doi.org/10.1080/17449200600743644openalex-snapshot
Mortality among Danish drug users released from prison
inferredcites →https://doi.org/10.1093/bjc/azh085openalex-snapshot
The Effectiveness Of Methadone Maintenance Treatment In Controlling Crime: An Australian Aggregate-Level Analysis
inferredcites →https://doi.org/10.1111/add.12551openalex-snapshot
The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study
inferredcites →https://doi.org/10.1111/j.1360-0443.2005.01089.xopenalex-snapshot
Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain
inferredcites →https://doi.org/10.1111/j.1360-0443.2007.02081.xopenalex-snapshot
Acute risk of drug‐related death among newly released prisoners in England and Wales
inferredcites →https://doi.org/10.1111/j.1360-0443.2007.02090.xopenalex-snapshot
Exposure to opioid maintenance treatment reduces long‐term mortality
inferredcites →https://doi.org/10.1111/j.1360-0443.2009.02633.xopenalex-snapshot
Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention
inferredcites →https://doi.org/10.1111/j.1360-0443.2009.02826.xopenalex-snapshot
Does opioid substitution treatment in prisons reduce injecting‐related HIV risk behaviours? A systematic review
inferredcites →https://doi.org/10.1111/j.1360-0443.2010.02990.xopenalex-snapshot
Meta‐analysis of drug‐related deaths soon after release from prison
inferredcites →https://doi.org/10.1111/j.1360-0443.2010.03140.xopenalex-snapshot
Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies
inferredcites →https://doi.org/10.1111/j.1360-0443.2011.03618.xopenalex-snapshot
Effect of prison‐based opioid substitution treatment and post‐release retention in treatment on risk of re‐incarceration
inferredcites →https://doi.org/10.1111/j.1360-0443.2011.03676.xopenalex-snapshot
The effectiveness of opioid maintenance treatment in prison settings: a systematic review
inferredcites →https://doi.org/10.1111/j.1360-0443.2011.03694.xopenalex-snapshot
Opioid maintenance in European prisons: is the treatment gap closing?
inferredcites →https://doi.org/10.1111/j.1467-842x.2003.tb00615.xopenalex-snapshot
Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long‐term Intervention with Pravastatin in Ischaemic Disease (LIPID) study
inferredcites →https://doi.org/10.1111/j.1467-842x.2005.tb00253.xopenalex-snapshot
Mortality among prisoners: how accurate is the Australian National Death Index?
inferredcites →https://doi.org/10.1136/bmj.316.7129.426openalex-snapshot
Mortality from overdose among injecting drug users recently released from prison: database linkage study
inferredcites →https://doi.org/10.1136/bmj.326.7398.1064openalex-snapshot
Mortality in young offenders: retrospective cohort study
inferredcites →https://doi.org/10.1136/bmj.e5945openalex-snapshot
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
inferredcites →https://doi.org/10.1136/jech.48.1.101openalex-snapshot
Longitudinal and cross sectional mortality studies in injecting drug-users.
inferredcites →https://doi.org/10.1159/000199046openalex-snapshot
A Literature Review of International Implementation of Opioid Substitution Treatment in Prisons: Equivalence of Care?
inferredcites →https://doi.org/10.1177/002580249003000104openalex-snapshot
Mortality following Release from Prison
inferredcites →https://doi.org/10.1186/1940-0640-7-3openalex-snapshot
Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors
inferredcites →https://doi.org/10.1375/acri.39.1.20openalex-snapshot
Ex-Prisoners, Homelessness and the State in Australia
inferredcites →https://doi.org/10.5055/jom.2009.0024openalex-snapshot
Overcoming obstacles to implementing methadone maintenance therapy for prisoners: Implications for policy and practice
inferredcites →https://doi.org/10.5167/uzh-17408openalex-snapshot
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
inferredcites →https://doi.org/10.5694/j.1326-5377.1999.tb123495.xopenalex-snapshot
Opioid overdose mortality in Australia, 1964–1997: birth‐cohort trends
inferredcites →https://doi.org/10.5694/j.1326-5377.1999.tb127675.xopenalex-snapshot
Mortality associated with New South Wales methadone programs in 1994: lives lost and saved
inferredcites →https://doi.org/10.5694/j.1326-5377.2007.tb01307.xopenalex-snapshot
Suicide risk among recently released prisoners in New South Wales, Australia
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4774188openalex-extracted
Closing the Opioid Use Disorder Treatment Gap: Expanding Nurse Practitioners' Prescriptive Authority
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2019.6373openalex-snapshot
Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.42688openalex-snapshot
Association Between Assistance With Medicaid Enrollment and Use of Health Care After Incarceration Among Adults With a History of Substance Use
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.2732openalex-snapshot
Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes
inferred← citeshttps://doi.org/10.1001/jamapsychiatry.2021.0976openalex-snapshot
The impact of opioid agonist treatment delivered in different settings on all-cause mortality and specific causes of death:A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/978-3-030-65672-0_10openalex-snapshot
Substance Use: A Social Emergency Medicine Perspective
inferred← citeshttps://doi.org/10.1007/978-3-031-37480-7_11openalex-snapshot
Medications for Opioid Use Disorder (MOUDs): What Psychology Service Providers Should Know to Improve Correctional Care
inferred← citeshttps://doi.org/10.1007/978-3-031-65839-6_38openalex-snapshot
Treating Substance Use Disorder Problems in the Endocarditis Patient
inferred← citeshttps://doi.org/10.1007/s10461-022-03817-zopenalex-snapshot
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
inferred← citeshttps://doi.org/10.1007/s11469-018-9936-2openalex-snapshot
A Narrative Review of Pharmacotherapy Treatment for Opioid Addiction and Application in a Community-Based Model in Victoria, Australia
inferred← citeshttps://doi.org/10.1007/s11524-019-00353-5openalex-snapshot
The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia
inferred← citeshttps://doi.org/10.1007/s11916-024-01286-8openalex-snapshot
Methadone and Buprenorphine in the Perioperative Setting: A Review of the Literature
inferred← citeshttps://doi.org/10.1007/s12103-024-09784-6openalex-snapshot
Medications for Opioid Use Disorder Helpful or Placebo? An Evaluation of the Effectiveness of MOUD in Carceral Settings
inferred← citeshttps://doi.org/10.1007/s12103-026-09916-0openalex-snapshot
From Recidivism Reduction to Rehabilitation: Evaluating the Broader Effects of Prison-Based Drug Treatment
inferred← citeshttps://doi.org/10.1007/s40263-018-0513-9openalex-snapshot
Pharmacogenetics of Opioid Use Disorder Treatment
inferred← citeshttps://doi.org/10.1007/s40501-018-0153-1openalex-snapshot
Risk Factors for Opioid Overdose
inferred← citeshttps://doi.org/10.1016/j.amepre.2017.12.022openalex-snapshot
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
inferred← citeshttps://doi.org/10.1016/j.amepre.2021.06.014openalex-snapshot
Legal System Involvement and Opioid-Related Overdose Mortality in U.S. Department of Veterans Affairs Patients
inferred← citeshttps://doi.org/10.1016/j.annepidem.2019.02.004openalex-snapshot
A joint spatial model of opioid-associated deaths and treatment admissions in Ohio
inferred← citeshttps://doi.org/10.1016/j.cct.2015.01.005openalex-snapshot
Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: Rationale and design of a randomized controlled effectiveness trial
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2015.06.011openalex-snapshot
Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2015.12.021openalex-snapshot
Opioid substitution therapy: Lowering the treatment thresholds
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2016.08.640openalex-snapshot
Resumption of injecting drug use following release from prison in Australia
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2017.10.035openalex-snapshot
Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2017.11.023openalex-snapshot
A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2018.04.034openalex-snapshot
Beyond the walls: Risk factors for overdose mortality following release from the Philadelphia Department of Prisons
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2018.09.003openalex-snapshot
Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2020.107858openalex-snapshot
Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2020.108292openalex-snapshot
Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2020.108392openalex-snapshot
Randomized trial of methadone treatment of arrestees: 24-month post-release outcomes
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108529openalex-snapshot
Does incarceration influence patients’ goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109543openalex-snapshot
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109730openalex-snapshot
Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: A discrete-time survival analysis
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.109867openalex-snapshot
Neighborhood-level association between release from incarceration and fatal overdose, Rhode Island, 2016–2020
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.110896openalex-snapshot
Exploring mental health comorbidities and opioid agonist treatment coverage among people in prison: A national cohort study 2010–2019
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2024.111274openalex-snapshot
Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2024.111377openalex-snapshot
Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2025.112950openalex-snapshot
Bridging the gap: Post-release outcome evaluation of the first jail-based telemedicine buprenorphine program
inferred← citeshttps://doi.org/10.1016/j.drugpo.2018.04.003openalex-snapshot
Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review
inferred← citeshttps://doi.org/10.1016/j.drugpo.2020.102707openalex-snapshot
Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky
inferred← citeshttps://doi.org/10.1016/j.drugpo.2020.102841openalex-snapshot
Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study
inferred← citeshttps://doi.org/10.1016/j.drugpo.2021.103401openalex-snapshot
Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP): A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.drugpo.2021.103480openalex-snapshot
Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada
inferred← citeshttps://doi.org/10.1016/j.drugpo.2021.103558openalex-snapshot
Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program
inferred← citeshttps://doi.org/10.1016/j.drugpo.2021.103572openalex-snapshot
Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison
inferred← citeshttps://doi.org/10.1016/j.drugpo.2022.103803openalex-snapshot
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers
inferred← citeshttps://doi.org/10.1016/j.drugpo.2023.104218openalex-snapshot
Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia
inferred← citeshttps://doi.org/10.1016/j.drugpo.2024.104369openalex-snapshot
Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia
inferred← citeshttps://doi.org/10.1016/j.drugpo.2025.105126openalex-snapshot
“A never-ending cycle”: The structural, economic and social (re)production of blood-borne virus transmission and bacterial infection amongst people who inject drugs in Queensland prisons
inferred← citeshttps://doi.org/10.1016/j.idm.2017.08.002openalex-snapshot
Structural sensitivity in HIV modeling: A case study of vaccination
inferred← citeshttps://doi.org/10.1016/j.josat.2023.208971openalex-snapshot
Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209264openalex-snapshot
Met and unmet prison-based treatment needs for people who are incarcerated with a history of substance use disorder: A nationwide cohort study
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209277openalex-snapshot
Prompt access to outpatient care post-incarceration among adults with a history of substance use: Predisposing, enabling, and need-based factors
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209438openalex-snapshot
Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.jsat.2016.05.002openalex-snapshot
Impact of Medication-Assisted Treatment for Opioid Addiction on Medicaid Expenditures and Health Services Utilization Rates in Vermont
inferred← citeshttps://doi.org/10.1016/j.jsat.2016.08.001openalex-snapshot
Monitoring a Prison Opioid Treatment Program Over a Period of Change to Clinical Governance Arrangements, 2007–2013
inferred← citeshttps://doi.org/10.1016/j.jsat.2018.12.003openalex-snapshot
Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review
inferred← citeshttps://doi.org/10.1016/j.jsat.2019.07.004openalex-snapshot
The impact of drug court participation on mortality: 15-year outcomes from a randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.jsat.2020.01.009openalex-snapshot
Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108349openalex-snapshot
Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108647openalex-snapshot
Assessing the determinants of completing OAT induction and long-term retention: A population-based study in British Columbia, Canada
inferred← citeshttps://doi.org/10.1016/j.socscimed.2026.118946openalex-snapshot
The impact of incarceration on health: A global systematic review
inferred← citeshttps://doi.org/10.1016/j.ssmph.2022.101274openalex-snapshot
Mortality after release from incarceration in New Zealand by gender: A national record linkage study
inferred← citeshttps://doi.org/10.1016/j.tcm.2019.11.007openalex-snapshot
Infective endocarditis in intravenous drug users
inferred← citeshttps://doi.org/10.1016/s0140-6736(14)62338-2openalex-snapshot
Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial
inferred← citeshttps://doi.org/10.1016/s0140-6736(16)30769-3openalex-snapshot
Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners
inferred← citeshttps://doi.org/10.1016/s0140-6736(19)32229-9openalex-snapshot
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
inferred← citeshttps://doi.org/10.1016/s1473-3099(25)00630-9openalex-snapshot
Best practice guidelines for viral hepatitis service delivery in prisons
inferred← citeshttps://doi.org/10.1016/s2215-0366(15)00235-7openalex-snapshot
Variation in mortality risk of people released from prison
inferred← citeshttps://doi.org/10.1016/s2468-2667(21)00007-4openalex-snapshot
Periods of altered risk for non-fatal drug overdose: a self-controlled case series
inferred← citeshttps://doi.org/10.1016/s2468-2667(24)00098-7openalex-snapshot
Estimated effects of opioid agonist treatment in prison on all-cause mortality and overdose mortality in people released from prison in Norway: a prospective analysis of data from the Norwegian Prison Release Study (nPRIS)
inferred← citeshttps://doi.org/10.1016/s2468-2667(24)00105-1openalex-snapshot
National approaches to reduce mortality after prison release
inferred← citeshttps://doi.org/10.1016/s2468-2667(24)00160-9openalex-snapshot
Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1017/s2045796017000506openalex-snapshot
Modifiable risk factors for external cause mortality after release from prison: a nested case–control study
inferred← citeshttps://doi.org/10.1038/s41380-018-0094-5openalex-snapshot
Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1038/s41598-025-23552-4openalex-snapshot
Mortality and return to custody of individuals with a history of drug use one year post-release from the New South Wales custodial system
inferred← citeshttps://doi.org/10.1055/a-1173-9588openalex-snapshot
Zusammenfassende Darstellung der wissenschaftlichen Grundlagen der Richtlinie der Bundesärztekammer zur Durchführung der substitutionsgestützten Behandlung Opioidabhängiger
inferred← citeshttps://doi.org/10.1055/a-1378-9249openalex-snapshot
Die Substitutionstherapie Opioidabhängiger in Deutschland: Auswirkungen der 3. BtMVVÄndV aus der Sicht substituierender Ärztinnen und Ärzte
inferred← citeshttps://doi.org/10.1055/a-1669-9033openalex-snapshot
Substitutionsbehandlung bei Opiatabhängigen im Maßregelvollzug
inferred← citeshttps://doi.org/10.1055/a-1884-8689openalex-snapshot
Vermeidung drogeninduzierter Mortalität nach Haftentlassung
inferred← citeshttps://doi.org/10.1056/nejmra1604339openalex-snapshot
Treatment of Opioid-Use Disorders
inferred← citeshttps://doi.org/10.1056/nejmsa2415987openalex-snapshot
Medications for Opioid Use Disorder in County Jails — Outcomes after Release
inferred← citeshttps://doi.org/10.1080/00952990.2020.1828440openalex-snapshot
Opioid agonist treatment is highly protective against overdose death among a U.S. statewide population of justice-involved adults
inferred← citeshttps://doi.org/10.1080/07418825.2017.1341541openalex-snapshot
Examining All-cause and Cause-specific Mortality among Former Prisoners in Pennsylvania
inferred← citeshttps://doi.org/10.1080/10826084.2017.1388260openalex-snapshot
Frequent Drug Use and Negative Employment Outcomes among the Criminally Active
inferred← citeshttps://doi.org/10.1093/cid/civ481openalex-snapshot
Editorial Commentary:The Impact of Opiate Substitution Therapy and Highly Active Antiretroviral Therapy on Mortality Risk Among People Who Inject Drugs
inferred← citeshttps://doi.org/10.1093/ije/dyaa125openalex-snapshot
Data Resource Profile: The Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia
inferred← citeshttps://doi.org/10.1093/infdis/jiz673openalex-snapshot
Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda
inferred← citeshttps://doi.org/10.1093/oso/9780190675486.003.0008openalex-snapshot
Integrating Treatment for Opioid Use Disorders and HIV Services into Primary Care
inferred← citeshttps://doi.org/10.1097/adm.0000000000000381openalex-snapshot
Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal
inferred← citeshttps://doi.org/10.1097/adm.0000000000000788openalex-snapshot
Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy
inferred← citeshttps://doi.org/10.1097/qai.0000000000000624openalex-snapshot
Substance Use and HIV Among Female Sex Workers and Female Prisoners
inferred← citeshttps://doi.org/10.1097/yco.0000000000000174openalex-snapshot
Responding to illicit drug use in family practice
inferred← citeshttps://doi.org/10.1097/yic.0000000000000611openalex-snapshot
Focus on mood disorders, obsessive–compulsive disorders, and prisoners' treatments
inferred← citeshttps://doi.org/10.1108/ijoph-11-2024-0064openalex-snapshot
Facilitators and barriers to scaling up methadone maintenance therapy in Malaysian prisons: using nominal group technique with custodial staff
inferred← citeshttps://doi.org/10.1108/ijph-02-2020-0012openalex-snapshot
Punitive discontinuation of opioid agonist therapy during incarceration
inferred← citeshttps://doi.org/10.1108/ijph-04-2021-0033openalex-snapshot
Knowledge of the Good Samaritan Drug Overdose Act and possession of a naloxone kit among people recently released from prison
inferred← citeshttps://doi.org/10.1108/ijph-12-2017-0064openalex-snapshot
Comparative study between prison- and community-based treatment satisfaction for opioid use disorder in Lebanon
inferred← citeshttps://doi.org/10.1111/1468-0009.70048openalex-snapshot
The Largest Program for Opioid Use Disorder in a Statewide Carceral System: A Collaborative Multi‐Agency Initiative
inferred← citeshttps://doi.org/10.1111/add.12613openalex-snapshot
Commentary on D egenhardt et al. (2014): Access to opioid substitution therapy in prison is not enough—the crucial role of post‐release retention in preventing drug‐related harms
inferred← citeshttps://doi.org/10.1111/add.12646openalex-snapshot
Striking subgroup differences in substance‐related mortality after release from prison
inferred← citeshttps://doi.org/10.1111/add.12938openalex-snapshot
Incarceration and injection drug use in Baltimore, Maryland
inferred← citeshttps://doi.org/10.1111/add.12969openalex-snapshot
Impact of opioid substitution therapy for Scotland's prisoners on drug‐related deaths soon after prisoner release
inferred← citeshttps://doi.org/10.1111/add.13073openalex-snapshot
A cost‐effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence
inferred← citeshttps://doi.org/10.1111/add.13185openalex-snapshot
Commentary on Cousins et al. (2016): Accumulating evidence on risk of mortality on and off opioid substitution treatment
inferred← citeshttps://doi.org/10.1111/add.13200openalex-snapshot
Clinical risk factors for death after release from prison in Washington State: a nested case–control study
inferred← citeshttps://doi.org/10.1111/add.13208openalex-snapshot
Response to Bird et al.: The importance of post‐release engagement in treatment in estimating impacts on post‐release deaths
inferred← citeshttps://doi.org/10.1111/add.13265openalex-snapshot
Effectiveness of Scotland 's National Naloxone Programme for reducing opioid‐related deaths: a before (2006–10) versus after (2011–13) comparison
inferred← citeshttps://doi.org/10.1111/add.13391openalex-snapshot
Effectiveness of Scotland's national naloxone programme: response to letter to editor
inferred← citeshttps://doi.org/10.1111/add.13779openalex-snapshot
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England
inferred← citeshttps://doi.org/10.1111/add.13783openalex-snapshot
Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
inferred← citeshttps://doi.org/10.1111/add.13803openalex-snapshot
High risk of overdose death following release from prison: variations in mortality during a 15‐year observation period
inferred← citeshttps://doi.org/10.1111/add.13857openalex-snapshot
Commentary on Marsden et al . (2017): While epidemiological studies can help to identify areas of overdose risk, we need more focused hypothesis‐driven trials to inform clinical intervention strategies
inferred← citeshttps://doi.org/10.1111/add.14053openalex-snapshot
Patterns of substance use and mortality risk in a cohort of ‘hard‐to‐reach’ polysubstance users
inferred← citeshttps://doi.org/10.1111/add.14106openalex-snapshot
Incidence and risk factors for mortality after release from prison in Australia: a prospective cohort study
inferred← citeshttps://doi.org/10.1111/add.14620openalex-snapshot
Criminal justice outcomes over 5 years after randomization to buprenorphine‐naloxone or methadone treatment for opioid use disorder
inferred← citeshttps://doi.org/10.1111/add.15004openalex-snapshot
Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug‐related poisoning deaths? A retrospective cohort study
inferred← citeshttps://doi.org/10.1111/add.15077openalex-snapshot
The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study
inferred← citeshttps://doi.org/10.1111/add.15168openalex-snapshot
Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia
inferred← citeshttps://doi.org/10.1111/add.15565openalex-snapshot
Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters
inferred← citeshttps://doi.org/10.1111/add.15679openalex-snapshot
Commentary on Victor et al. : Preventing overdose deaths following release from incarceration—context is crucial
inferred← citeshttps://doi.org/10.1111/add.15736openalex-snapshot
Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia
inferred← citeshttps://doi.org/10.1111/add.15737openalex-snapshot
Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada
inferred← citeshttps://doi.org/10.1111/add.15971openalex-snapshot
High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment
inferred← citeshttps://doi.org/10.1111/add.16071openalex-snapshot
Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17
inferred← citeshttps://doi.org/10.1111/add.16117openalex-snapshot
Commentary on Lim et al.: Mortality database linkages—A critical methodology to understand the structural drivers of the overdose crisis
inferred← citeshttps://doi.org/10.1111/add.16766openalex-snapshot
Extended‐release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review
inferred← citeshttps://doi.org/10.1111/add.70095openalex-snapshot
Identifying key risk factors for intentional self‐harm, including suicide, among a cohort of people prescribed opioid agonist treatment: A predictive modelling study
inferred← citeshttps://doi.org/10.1111/add.70170openalex-snapshot
Potential health impacts of comprehensive access to opioid use disorder treatment in United States correctional facilities: A synthetic analysis
inferred← citeshttps://doi.org/10.1111/dar.12317openalex-snapshot
The extramedical use and diversion of opioid substitution medications and other medications in prison settings in A ustralia following the introduction of buprenorphine–naloxone film
inferred← citeshttps://doi.org/10.1111/dar.12442openalex-snapshot
A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia
inferred← citeshttps://doi.org/10.1111/dar.70004openalex-snapshot
Gender and Overdose Risk Factors Among Clients Entering Residential Treatment for Opioid Use
inferred← citeshttps://doi.org/10.1111/dar.70096openalex-snapshot
Experiences of People Who Discontinue Long‐Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia
inferred← citeshttps://doi.org/10.1111/dar.70161openalex-snapshot
Health, Social and Recidivism Outcomes Among People Who Have Been Incarcerated in New South Wales, Australia: Study Protocol and Cohort Profile for the Prison Outcomes STudy ( POST )
inferred← citeshttps://doi.org/10.1111/liv.15469openalex-snapshot
Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study
inferred← citeshttps://doi.org/10.1136/bmjopen-2013-004666openalex-snapshot
Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
inferred← citeshttps://doi.org/10.1136/bmjopen-2019-030605openalex-snapshot
Protocol for the Data-Linkage Alcohol Cohort Study (DACS): investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data
inferred← citeshttps://doi.org/10.1136/bmjopen-2020-045601openalex-snapshot
Violence-related deaths among people released from incarceration: protocol for a systematic review
inferred← citeshttps://doi.org/10.1136/bmjopen-2021-048944openalex-snapshot
Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis
inferred← citeshttps://doi.org/10.1136/bmjopen-2024-090736openalex-snapshot
Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder
inferred← citeshttps://doi.org/10.1136/emermed-2022-212755openalex-snapshot
Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia
inferred← citeshttps://doi.org/10.1136/jech-2014-204295openalex-snapshot
Suicide in adults released from prison in Queensland, Australia: a cohort study
inferred← citeshttps://doi.org/10.1155/2024/6359691openalex-snapshot
Guanfacine Treatment in a Patient with Intravenous Buprenorphine/Naloxone Misuse
inferred← citeshttps://doi.org/10.1159/000432395openalex-snapshot
Opioid Maintenance Treatment - A Call for a Joint European Quality Care Approach
inferred← citeshttps://doi.org/10.1177/0004865815620703openalex-snapshot
How the prison-to-community transition risk environment influences the experience of men with co-occurring mental health and substance use disorder
inferred← citeshttps://doi.org/10.1177/00208728211048926openalex-snapshot
Continuity of care for drug users in prison and beyond: A qualitative insight
inferred← citeshttps://doi.org/10.1177/00220426241229972openalex-snapshot
Attitudes and Subjective Norms Regarding Medication for Opioid Use Disorder Among Individuals in Treatment for Opioid Use Disorder in the Greater St. Louis Area
inferred← citeshttps://doi.org/10.1177/00914509211060723openalex-snapshot
Addiction Treatment as Prison Governance: A Critical Discourse Analysis of Methadone Delivery in Kyrgyz Prisons
inferred← citeshttps://doi.org/10.1177/00914509251371745openalex-snapshot
The Overdose Risk Environment for People Who Inject Drugs Transitioning From Prison to Community in Australia
inferred← citeshttps://doi.org/10.1177/00938548231166155openalex-snapshot
A Systematic Review and Narrative Synthesis of Interventions to Address Substance Use Disorders and Other Mental Health Disorders in Prison Settings With a Focus on Low- and Middle-Income Countries
inferred← citeshttps://doi.org/10.1177/0306624x17747829openalex-snapshot
Narratives of Young Men With Injecting Drug Use Histories Leaving Adult Prison
inferred← citeshttps://doi.org/10.1177/0306624x231168596openalex-snapshot
Leaving Their Drugs at the Gate? Exploring Changes in Drug Use From Before to During Incarceration in Norway
inferred← citeshttps://doi.org/10.1177/0734016820981629openalex-snapshot
Championing Change to Save Lives: A Call to Action to Implement Reforms to Increase Use of Medications to Treat Opioid Use Disorder in Correctional Settings
inferred← citeshttps://doi.org/10.1177/10398562211059086openalex-snapshot
Long-acting injectable buprenorphine – ‘best practice’ opioid agonist therapy for Australian prisoners
inferred← citeshttps://doi.org/10.1177/1078345819852133openalex-snapshot
Screening for Opioid Use Disorder in the Largest Jail in Arkansas: A Brief Report
inferred← citeshttps://doi.org/10.1177/107937391904100403openalex-snapshot
Deaths in Custody and following Release
inferred← citeshttps://doi.org/10.1177/11782218221138335openalex-snapshot
Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
inferred← citeshttps://doi.org/10.1177/29767342241238837openalex-snapshot
Perceptions of Community Corrections and Treatment Experience: A Qualitative Study Among People With Incarceration Histories Receiving Outpatient Methadone Treatment
inferred← citeshttps://doi.org/10.1186/s12879-022-07804-6openalex-snapshot
Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia
inferred← citeshttps://doi.org/10.1186/s12889-023-15673-0openalex-snapshot
Record linkage studies of drug-related deaths among adults who were released from prison to the community: a scoping review
inferred← citeshttps://doi.org/10.1186/s12889-025-23283-1openalex-snapshot
Global, regional, and national burden of opioid use disorder from 1990 to 2021: a statistical analysis of incidence, mortality, and disability-adjusted life years
inferred← citeshttps://doi.org/10.1186/s12913-025-13520-zopenalex-snapshot
Mind the gap: a quality improvement study to determine health care value of rapid-access telemedicine addiction treatment in recently incarcerated individuals
inferred← citeshttps://doi.org/10.1186/s12954-015-0089-3openalex-snapshot
Mortality in the Melbourne injecting drug user cohort study (MIX)
inferred← citeshttps://doi.org/10.1186/s12954-020-00412-0openalex-snapshot
Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study
inferred← citeshttps://doi.org/10.1186/s12954-021-00480-wopenalex-snapshot
“My first 48 hours out”: drug users’ perspectives on challenges and strategies upon release from prison
inferred← citeshttps://doi.org/10.1186/s12954-021-00525-0openalex-snapshot
Substance use and overdose risk: documenting the perspectives of formerly incarcerated persons in the Fraser East region of BC
inferred← citeshttps://doi.org/10.1186/s12954-023-00773-2openalex-snapshot
Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study
inferred← citeshttps://doi.org/10.1186/s12954-023-00774-1openalex-snapshot
HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice
inferred← citeshttps://doi.org/10.1186/s12954-024-01041-7openalex-snapshot
Is peer support a tipping point for the opioid use disorder crisis in Appalachia? Research holds the answer
inferred← citeshttps://doi.org/10.1186/s13690-021-00623-2openalex-snapshot
New hepatitis C virus infection, re-infection and associated risk behaviour in male Irish prisoners: a cohort study, 2019
inferred← citeshttps://doi.org/10.1186/s13722-019-0145-5openalex-snapshot
A conceptual model for understanding post-release opioid-related overdose risk
inferred← citeshttps://doi.org/10.1186/s13722-024-00486-2openalex-snapshot
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
inferred← citeshttps://doi.org/10.1186/s40352-020-00112-8openalex-snapshot
Factors associated with drug use in prison – results from the Norwegian offender mental health and addiction (NorMA) study
inferred← citeshttps://doi.org/10.1186/s40352-023-00209-wopenalex-snapshot
Medications for opioid use disorder during incarceration and post-release outcomes
inferred← citeshttps://doi.org/10.1186/s40352-024-00302-8openalex-snapshot
Treatment utilization among people with drug use disorders in prison: a national longitudinal cohort study
inferred← citeshttps://doi.org/10.1186/s40352-026-00451-yopenalex-snapshot
Telemedicine-based buprenorphine initiation and maintenance in rural jails: a retrospective observational study
inferred← citeshttps://doi.org/10.12927/hcq.2020.26146openalex-snapshot
Improving Health and Healthcare Access for People who Experience Imprisonment in Ontario
inferred← citeshttps://doi.org/10.12974/2313-1047.2023.10.08openalex-snapshot
Reentry Service Engagement Among a Reentry Population with Co-occurring Mental Health and Opioid Use Disorders in Massachusetts Jails
inferred← citeshttps://doi.org/10.1353/hpu.2023.0012openalex-snapshot
Characteristics of Substance Use Screening at Intake in a Sample of U.S. Jails
inferred← citeshttps://doi.org/10.1371/journal.pmed.1002625openalex-snapshot
Methadone maintenance treatment and mortality in people with criminal convictions: A population-based retrospective cohort study from Canada
inferred← citeshttps://doi.org/10.1371/journal.pmed.1002969openalex-snapshot
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
inferred← citeshttps://doi.org/10.1371/journal.pmed.1003002openalex-snapshot
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review
inferred← citeshttps://doi.org/10.1371/journal.pmed.1003239openalex-snapshot
Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis
inferred← citeshttps://doi.org/10.1371/journal.pmed.1003759openalex-snapshot
Fatal opioid overdoses during and shortly after hospital admissions in England: A case-crossover study
inferred← citeshttps://doi.org/10.1371/journal.pmed.1004049openalex-snapshot
Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia
inferred← citeshttps://doi.org/10.1371/journal.pone.0157512openalex-snapshot
Drug Toxicity Deaths after Release from Incarceration in Ontario, 2006-2013: Review of Coroner’s Cases
inferred← citeshttps://doi.org/10.1371/journal.pone.0192431openalex-snapshot
Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey
inferred← citeshttps://doi.org/10.1371/journal.pone.0306075openalex-snapshot
Receipt of Opioid Agonist Treatment in provincial correctional facilities in British Columbia is associated with a reduced hazard of nonfatal overdose in the month following release
inferred← citeshttps://doi.org/10.1377/hlthaff.2025.01733openalex-snapshot
Criminal Legal Referrals Were Associated With Delayed Substance Use Treatment, Disparity By Housing Status
inferred← citeshttps://doi.org/10.1515/pubhef-2020-0073openalex-snapshot
„Mehr als Substitution“ – Notwendigkeit von Harm Reduction-Maßnahmen für Drogenkonsumierende in Haft
inferred← citeshttps://doi.org/10.1596/978-1-4648-0426-7_ch6openalex-snapshot
Illicit Drug Dependence
inferred← citeshttps://doi.org/10.17116/sudmed201760230-35openalex-snapshot
The peculiarities of the comprehensive study of buprenorphine
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1054474/v1openalex-snapshot
Impact of Prerelease Methadone on Mortality Among People with HIV and Opioid Use Disorder After Prison Release: Results from a Randomized and Participant Choice Open-Label Trial in Malaysia
inferred← citeshttps://doi.org/10.2139/ssrn.4167143openalex-snapshot
Drug Treatment Perspectives and Experiences Among Family and Friends of People Who Use Illicit Opioids: A Mixed Methods Study
inferred← citeshttps://doi.org/10.2139/ssrn.5192800openalex-snapshot
Evidence-Based Addiction Care During Incarceration Reduces Post-Release Overdoses
showing the first 200 of 220 · page through all 220
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.